Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Voacamine is an alkaloid isolated from the bark of the Pescheria fuchsiae folia tree. It is an antimalarial drug approved for use in several African countries. Voacamine is also under... Voacamine is also under investigation for use in modulating multidrug-resistance in tumor cells.
- Mechanism
- Curator reviewed
Voacamine is possibly a substrate for P-glycoprotein (P-gp), an efflux pump responsible for multidrug resistance in tumor cells. Voacamine may compete with anticancer drugs such as doxorubicin for P-gp transport, decreasing removal of doxorubicin.
- Primary indication
- For the treatment of malaria.Curator reviewed
- Formula / weight
- C43H52N4O5 · 704.8968 g/mol (avg)
- Also known as
- Voacanginine · Vocamine
- Code names
- MMH-18
Resolves to
VCMIRXRRQJNZJT-XRMSBCOFSA-NSMILES[H][C@@]12C[C@H](CC)[C@]3([H])N(C1)CCC1=C(NC4=CC(=C(OC)C=C14)[C@@]1([H])C[C@]4([H])C(C(=O)OC)[C@@]([H])(CC5=C1NC1=CC=CC=C51)N(C)C\C4=C\C)[C@@]3(C2)C(=O)OCWhat you can answer from here — as of October 01, 2026
Which drugs share a target with Voacamine, and which of those have an active Phase 3 trial?